Medical Advisors

Gregory W. Albers, MD
Director, Stanford Stroke Center
Dr. Gregory W. Albers is the Director of the Stanford Stroke Center, which he co-founded in 1992. Under his leadership, the center has trained more than 40 clinical stroke specialists. Many now lead stroke centers at academic institutions around the world.
Dr. Albers’ primary research focuses on the diagnosis, management, and prevention of ischemic stroke. He was instrumental in developing RAPID, a medical imaging platform that helps physicians identify stroke patients with salvageable brain tissue.
RAPID was used to select patients for the EXTEND, EXTEND-IA, SWIFT PRIME, DEFUSE 3, and DAWN clinical trials. All five studies were published in the New England Journal of Medicine. Their findings led to landmark changes in both intravenous and endovascular stroke treatment. As a result, more stroke patients can now receive effective treatment.
Medical Training and Academic Career
Dr. Albers completed his medical training at Stanford, including a neurology residency and fellowship in cerebrovascular disease. He joined the Stanford faculty in 1989. The following year, he received the Lysia Forno Award for Teaching Excellence.
In 2011, Dr. Albers received the American Heart Association’s prestigious David G. Sherman Award for Outstanding Contributions to Stroke Research. He has also been recognized as one of the “Best Medical Specialists in North America – Cerebrovascular Disease” and among the “Country’s Best Heart and Stroke Doctors” in national physician surveys.
Stroke Research and Publications
Dr. Albers has authored more than 400 peer-reviewed articles on cerebrovascular disease. His research has helped advance stroke diagnosis, treatment, and patient selection for time-sensitive therapies.
Through his clinical research, academic leadership, and work in stroke care, Dr. Albers has made significant contributions to the field of ischemic stroke treatment and cerebrovascular disease.


